Leukemia Newswire

Leukemia Newswire

Comprehensive Real-Time News Feed for Leukemia.

Results 1 - 20 of 3,796 in Leukemia

  1. JAK2 inhibitor ruxolitinib shows promise in treating CMML patientsRead the original story w/Photo

    21 min ago | Medical News

    Chronic myelomonocytic leukemia is a rare type of myelodysplastic, myeloproliferative neoplasm characterized by increased numbers of peripheral monocytes and less than 20 percent blasts. CMML has few treatment options and patients only survive on average for 12 to 24 months.

    Comment?

  2. Study: New cases of cancer rising globally, but death rates falling in many countriesRead the original story w/Photo

    1 hr ago | Medical News

    New cases of virtually all types of cancer are rising in countries globally - regardless of income - but the death rates from cancer are falling in many countries, according to a new analysis of 28 cancer groups in 188 countries. Thanks to prevention and treatment, progress has been made in fighting certain cancers, such as childhood leukemia.

    Comment?

  3. Photo of young cancer patients embracing goes viralRead the original story w/Photo

    5 hrs ago | GlobalNews

    ... cancer patients at Pittsburgh Children's Hospital. Maliyah is battling neuroblastoma and Madelina acute myeloid leukemia. "Children helping other children is the best support," said Tazz. She captioned the photo: "This is the perfect example of ...

    Comment?

  4. Can Video Games Solve Public Health Problems?Read the original story w/Photo

    6 hrs ago | US News & World Report

    People ages 13 and over spent more than six hours a week playing video games in 2013 according to a recent Nielsen study. The games - six in all - arm players with weapons like "chemo bombs" and antibiotics to fight the leukemia monster, destroy bacteria, rescue healthy cells and annihilate tumors, all while collecting points and conquering levels.

    Comment?

  5. JAK2 Inhibitor Ruxolitinib has Minimal Toxicity, Promising Efficacy...Read the original story

    15 hrs ago | Newswise

    TAMPA, Fla. - Chronic myelomonocytic leukemia is a rare type of myelodysplastic, myeloproliferative neoplasm characterized by increased numbers of peripheral monocytes and less than 20 percent blasts.

    Comment?

  6. Support Ritchie Elementary student battling leukemiaRead the original story w/Photo

    14 hrs ago | Fauquier.com

    Ritchie Elementary School fourth grader Kaleb Leigh was diagnosed with leukemia four years ago.

    Comment?

  7. ASCO: MEDI4736 combined with tremelimumab results in acceptable toxicity in NSCLC patientsRead the original story w/Photo

    14 hrs ago | PhysOrg Weblog

    ... melanoma, this time by combining the checkpoint inhibitor tremelimumab with an anti-CD40 ... Chronic myelomonocytic leukemia (CMML) is a rare type of myelodysplastic, myeloproliferative neoplasm characterized by increased numbers of peripheral ...

    Comment?

  8. ASCO: Nivolumab treatment in melanoma patients has manageable safety profileRead the original story w/Photo

    14 hrs ago | PhysOrg Weblog

    ... in 2015. In recent years, an emphasis has been placed on chemoprevention - the use ... Chronic myelomonocytic leukemia (CMML) is a rare type of myelodysplastic, myeloproliferative neoplasm characterized by increased numbers of peripheral monocytes ...

    Comment?

  9. ASCO: JAK2 inhibitor ruxolitinib has promising efficacy in CMML patientsRead the original story w/Photo

    14 hrs ago | PhysOrg Weblog

    Chronic myelomonocytic leukemia is a rare type of myelodysplastic, myeloproliferative neoplasm characterized by increased numbers of peripheral monocytes and less than 20 percent blasts. CMML has few treatment options and patients only survive on average for 12 to 24 months.

    Comment?

  10. Florida-Based Pap Corps Raises $3.6M For Research At Sylvester Comprehensive Cancer CenterRead the original story w/Photo

    16 hrs ago | CBS Local

    ... in our labs and our clinics," said Stephen D. Nimer, M.D., Director of Sylvester and a world-renowned expert in leukemia. "By combining expertise in targeted therapies, immunotherapies, interventional radiology, stem cell transplantation and various ...

    Comment?

  11. Nearly $41,000 Donated To Help Dying Man See Hawaiian SunsetRead the original story w/Photo

    16 hrs ago | Patch.com

    Schwartz, a Ridgewood resident and lifelong environmentalist known as "Eco Ed," was diagnosed with acute myeloid leukemia in late 2013. The cancer attacks the bone marrow, which generates healthy blood cells.

    Comment?

  12. Cleveland Indians Shave Heads to Support Cancer-Stricken ChildRead the original story w/Photo

    17 hrs ago | Breitbart.com

    Cleveland Indians players and coaches shaved their heads in a show of support for teammate Mike Aviles' daughter, who suffers from leukemia and prepares to undergo chemotherapy. Over the last week nearly every member of the Indians have either shaved their heads or received a buzz cut to show support for Aviles' 4-year-old daughter, Adriana, diagnosed with the deadly disease earlier this month at Cleveland Clinic.

    Comment?

  13. Estimating the global burden of cancer in 2013; 14.9 million new cases worldwideRead the original story w/Photo

    18 hrs ago | PhysOrg Weblog

    ... for developing esophageal cancer between birth and age 79, with 1 in 73 men diagnosed compared with 1 in 203 women. Leukemia: There were 414,000 news cases and 265,000 deaths. Leukemia caused 9.3 million DALYs, with 78 percent occurring in ...

    Comment?

  14. GlycoMimetics to Present at the Jefferies 2015 Healthcare ConferenceRead the original story

    19 hrs ago | Business Wire

    ... commercialization of rivipansel. A GlycoMimetics wholly-owned candidate therapy (GMI-1271) for acute myeloid leukemia (AML) and other blood disorders is also in clinical trials. Glycomimetics are molecules that mimic the structure of carbohydrates ...

    Comment?

  15. Actinium Clinical Update on Actimab-A Provided at Targeted Alpha Therapy SymposiumRead the original story w/Photo

    21 hrs ago | Market Wire

    ... Advisory Board, presented "Targeted Alpha-Particle Therapy with Actinium-225 (225Ac)-Lintuzumab for Acute Myeloid Leukemia (AML) Alone and in Combination with Low-Dose Cytarabine (LDAC)". A review of the target (CD33), the antibody (Lintuzumab, also ...

    Comment?

  16. Acute Myeloid Leukemia Therapeutics Market Growth Report Up To 2020: Radiant Insights, IncRead the original story

    23 hrs ago | PR-inside.com

    2015-05-28 12:27:08 - Radiantinsights.com has include " Acute Myeloid Leukemia Therapeutics Market Report To 2020" Size, Share, Growth Prospects to their Database. Treatment and prognosis in AML is strongly influenced by a patient's age, and their ...

    Comment?

  17. New cancer cases rise globally, but death rates are declining in many countriesRead the original story w/Photo

    Yesterday | EurekAlert!

    New cases of virtually all types of cancer are rising in countries globally - regardless of income - but the death rates from cancer are falling in many countries, according to a new analysis of 28 cancer groups in 188 countries. Thanks to prevention and treatment, progress has been made in fighting certain cancers, such as childhood leukemia.

    Comment?

  18. MacroGenics, Inc. Preclinical Research On MGD006 DART Molecule Published In /iRead the original story

    Wednesday | BioSpace

    ... receptor alpha chain, is expressed on malignant cells, including leukemic stem cells (LSC), in acute myeloid leukemia (AML) and other hematological diseases. The primary mechanism of action of MGD006 is its ability to redirect T lymphocytes to kill ...

    Comment?

  19. Amgen To Advance Understanding Of The Treatment Of Blood Cancers At...Read the original story

    Wednesday | BioSpace

    The data reinforce Amgen's commitment to advancing the care of patients with hematologic malignancies through the development of novel treatment approaches and continued evaluation of marketed products. "We focus on blood cancers that have high unmet medical need, such as multiple myeloma and acute lymphoblastic leukemia, to make a positive impact for patients who desperately need more options," said , M.D., executive vice president of Research and Development at Amgen.

    Comment?

  20. Global Gene Therapy 2015 - Technologies, Markets and Companies Forecasts to 2024Read the original story w/Photo

    23 hrs ago | GlobeNewswire

    ... the FDA has further tightened the regulatory control on gene therapy. A further setback was the reports of leukemia following use of retroviral vectors in successful gene therapy for adenosine deaminase deficiency. Several clinical trials were put ...

    Comment?